Repare Therapeutics

OverviewSuggest Edit

Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare Therapeutics's platform combines CRISPR‐enabled gene-editing target discovery technology with high‐resolution protein crystallography, computational biology, medicinal chemistry, and clinical informatics.

TypePublic
Founded2016
HQMontréal, CA
Websitereparerx.com

Latest Updates

Employees (est.) (Jul 2021)102
Job Openings7
Share Price (Sept 2021)$31.3(-7%)
Cybersecurity ratingAMore

Key People/Management at Repare Therapeutics

Lloyd M. Segal

Lloyd M. Segal

President & CEO and Director
Steve Forte

Steve Forte

EVP, Chief Financial Officer
Maria Koehler

Maria Koehler

EVP & Chief Medical Officer
Michael Zinda

Michael Zinda

EVP, Chief Scientific Officer
Cameron Black

Cameron Black

EVP, Discovery
Kim Seth

Kim Seth

EVP, Head of Business & Corporate Development
Show more

Repare Therapeutics Office Locations

Repare Therapeutics has offices in Montréal and Cambridge
Montréal, CA (HQ)
7210 Rue Frederick Banting #100, Saint-Laurent
Cambridge, MA, US
One Broadway, 1 Broadway 15th Floor
Show all (2)

Repare Therapeutics Financials and Metrics

Repare Therapeutics Revenue

Market capitalization (7-Sept-2021)

1.2b

Closing stock price (7-Sept-2021)

31.3
Repare Therapeutics's current market capitalization is $1.2 b.
Show all financial metrics

Repare Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Repare Therapeutics Online and Social Media Presence

Embed Graph

Repare Therapeutics Blogs

Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb

Bristol Myers Squibb to leverage Repare’s proprietary SNIPRx® synthetic lethal discovery platform to identify multiple oncology drug candidates $65 million upfront payment including $15 million in equity investment Repare Therapeutics eligible to receive development, regulatory and commercial milest…

Repare Therapeutics Appoints Steve Forte as CFO and Samarth Kulkarni to its Board of Directors

Cambridge, MA & Montreal, QC – Repare Therapeutics, a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations, announced today that it has made two additions to its leadershi…

Repare Therapeutics Frequently Asked Questions

  • When was Repare Therapeutics founded?

    Repare Therapeutics was founded in 2016.

  • Who are Repare Therapeutics key executives?

    Repare Therapeutics's key executives are Lloyd M. Segal, Steve Forte and Maria Koehler.

  • How many employees does Repare Therapeutics have?

    Repare Therapeutics has 102 employees.

  • Who are Repare Therapeutics competitors?

    Competitors of Repare Therapeutics include SpringWorks Therapeutics, Agios Pharmaceuticals and Blueprint Medicines.

  • Where is Repare Therapeutics headquarters?

    Repare Therapeutics headquarters is located at 7210 Rue Frederick Banting #100, Saint-Laurent, Montréal.

  • Where are Repare Therapeutics offices?

    Repare Therapeutics has offices in Montréal and Cambridge.

  • How many offices does Repare Therapeutics have?

    Repare Therapeutics has 2 offices.